FDA Inspection
Eric J. Lawitz, M.D.Eric J. Lawitz, M.D. – FDA Inspection, Mar 3, 2017
Record Details
This FDA Inspection record concerns Eric J. Lawitz, M.D., with an inspection on March 3, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 5b8da1ab-02b8-41fb-acb6-70da768c1d0e
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1006414
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Eric J. Lawitz, M.D.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| January 19, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 24, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 24, 2012 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 14, 2010 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Eric J. Lawitz, M.D.
- FDA Inspection 1227747 - 2024-01-19
- FDA Inspection 837585 - 2013-06-24
- FDA Inspection 797771 - 2012-08-24
- FDA Inspection 662046 - 2010-05-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.